Skip to main content

Optimapharm Further Expands in the US to Enhance Customer Collaboration

By October 28, 2022May 2nd, 2023No Comments

Optimapharm Further Expands in the US to Enhance Customer Collaboration

We Deliver on
Your Promises

In line with its strategic growth plans, Optimapharm has opened a new office in Boston, Massachusetts this September. The role of this office will be to further support our current operations in North America and to ensure continued excellence in delivery to our existing and future clients.

“As we continue to expand our mid-market offering, we look forward to joining the life-sciences ecosystem of the very dynamic Boston area! Our investment into the region, supported by our talented team, significantly enhances Optimapharm’s delivery capabilities,” said Ivana Waller, CEO of Optimapharm


Founded in 2006, Optimapharm, with 27 offices in Europe and North America, operates in more than 40 countries. Optimapharm is a mid-market CRO providing full-service solutions and unrivalled access to patients and Investigators, covering markets with a total population of over 900 million people. Optimapharm conducts phase I –IV studies in all therapeutic areas with a specific focus on Oncology, Neurosciences, Cardio-endocrinology-metabolic, and infectious diseases. With very strong operational teams, Optimapharm is also a leading CRO for Medical Device companies and has a reputation for excellence in rescuing studies.

Optimapharm USA Inc. 800 Boylston Street | Prudential Tower, 16th Floor | Boston, Massachusetts | 02199 |
United States of America.

“I wanted to say thank you for your superb support and collaboration this year. I am looking forward to work with you in 2019 as it is a pleasure to work with you and your team.”

Senior Manager Partner

Let’s talk about your pharma study needs